Drug Manufacturers - Specialty & Generic
BIOA
8.59
price up icon4.25%   0.35
pre-market  Pre-market:  8.65   0.06   +0.70%

Bioage Labs Inc (BIOA)
full-star
loading
Overview News Price History Discussions Forecast
Bioage Labs Inc stock is traded at $8.59, with a volume of 261.72K. It is up +4.25% in the last 24 hours and up +60.26% over the past month. Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
See More
Previous Close:
$8.24
Open:
$8.29
24h Volume:
261.72K
Relative Volume:
0.83
Market Cap:
$307.95M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+11.27%
1M Performance:
+60.26%
6M Performance:
+109.00%
1Y Performance:
-53.32%
1-Day Range:
Value
$8.285
$8.98
1-Week Range:
Value
$7.60
$8.98
52-Week Range:
Value
$2.88
$20.37

Bioage Labs Inc Stock (BIOA) Company Profile

Name
Name
Bioage Labs Inc
Name
Sector
Healthcare (1132)
Name
Industry
Drug Manufacturers - Specialty & Generic (84)
Name
Phone
510-806-1445
Name
Address
5885 HOLLIS STREET, EMERYVILLE
Name
Employee
64
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
BIOA's Discussions on Twitter

Compare BIOA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
BIOA
Bioage Labs Inc
 8.59 295.45M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
 115.89 51.60B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
 14.06 44.51B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
 9.60 42.35B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
 24.28 28.04B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
 474.72 20.52B 3.08B 1.24B 1.07B 25.61

Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-22-25 Upgrade Citigroup Neutral → Buy
Feb-28-25 Initiated William Blair Mkt Perform
Dec-10-24 Downgrade Morgan Stanley Overweight → Underweight
Dec-09-24 Downgrade Citigroup Buy → Neutral
Dec-09-24 Downgrade Jefferies Buy → Hold
Oct-21-24 Initiated Citigroup Buy
Oct-21-24 Initiated Jefferies Buy
Oct-21-24 Initiated Morgan Stanley Overweight
View All

Bioage Labs Inc Stock (BIOA) Latest News

pulisher
Nov 20, 2025

Is BioAge Labs Inc. (Y7G) stock a buy on weakness2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How interest rate cuts could boost BioAge Labs Inc. stock2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is BioAge Labs Inc. stock recession proofWeekly Stock Report & Weekly Breakout Opportunity Watchlist - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is BioAge Labs Inc. stock a buy before product launchesMarket Volume Report & Weekly Top Stock Performers List - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is BioAge Labs Inc. (Y7G) stock supported by free cash flowJuly 2025 Setups & AI Powered Market Entry Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to use Fibonacci retracement on BioAge Labs Inc.Gap Up & Verified Stock Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Order flow analysis tools used on BioAge Labs Inc.Entry Point & Low Risk Entry Point Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will BioAge Labs Inc. (Y7G) stock sustain uptrend momentumTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How BioAge Labs Inc. (Y7G) stock stacks up against competitorsQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will BioAge Labs Inc. (Y7G) stock hit analyst forecastsQuarterly Portfolio Review & Advanced Swing Trade Entry Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How supply shortages influence BioAge Labs Inc. (Y7G) stockJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com India

Nov 18, 2025
pulisher
Nov 17, 2025

BIOA: NLRP3 inhibitor targets cardiovascular risk in obesity; APJ agonist INDs planned next year - TradingView

Nov 17, 2025
pulisher
Nov 16, 2025

BioAge Labs (BIOA) Price Target Increased by 20.83% to 9.86 - Nasdaq

Nov 16, 2025
pulisher
Nov 16, 2025

BioAge Labs Inc. stock trendline breakdownGold Moves & Fast Entry Momentum Trade Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Can BioAge Labs Inc. stock resist sector downturnsWeekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Published on: 2025-11-15 16:22:46 - newser.com

Nov 15, 2025

Bioage Labs Inc Stock (BIOA) Financials Data

There is no financial data for Bioage Labs Inc (BIOA). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Similar to BIOA

drug_manufacturers_specialty_generic HIMS
$33.62
price down icon 6.17%
drug_manufacturers_specialty_generic ELAN
$21.24
price down icon 1.03%
drug_manufacturers_specialty_generic RDY
$13.90
price down icon 1.07%
drug_manufacturers_specialty_generic VTRS
$10.19
price down icon 2.58%
drug_manufacturers_specialty_generic NBIX
$138.98
price up icon 0.67%
drug_manufacturers_specialty_generic UTHR
$474.72
price down icon 0.38%
Open in Yahoo | Open in Google | Open in Finviz | Open in MarketWatch | Open in EDGAR | Open in Reuters
Cap:     |  Volume (24h):